Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Physicians fine-tune use of diabetes drugs after recent CV safety results
-
- Family, peer support needed to address pediatric obesity
- Menopausal weight gain presents surmountable challenge
- ADA recognizes diabetes psychologist
- Isoechoic thyroid nodules not always ‘low risk,’ benign Stephanie L. Lee, MD, PhD, ECNU
- Changes in metabolic risk factors, biochemical markers observed years before type 2 diabetes onset
- Coexisting celiac disease, type 1 diabetes reduce height in children
- Delayed TSH elevation associated with invasive procedures in neonatal ICU newborns
- Diabetes does not affect overall survival in prostate cancer
-
- DKA at type 1 diabetes diagnosis worsens glycemic control
- Glycemic control linked with diabetes-related quality of life in young patients
- Grading system may predict recurrence, progression of pituitary neuroendocrine tumors
- High DHEAS increases early puberty risk in girls
- Hormone therapy associated with hearing loss in postmenopausal women
- Long-term denosumab therapy safe, effective in postmenopausal osteoporosis
- Medical treatment for primary hyperparathyroidism impairs endothelial function
- Oral contraceptives associated with worsening lipid profile in PCOS
-
- Premature, early menopause increase risk for type 2 diabetes
- Transition to denosumab monotherapy after combination results in favorable BMD changes
- TV in child’s bedroom an independent risk factor for overweight
- Weight at birth may predict overweight, obesity status in second grade
- Global burden of diabetes complications ‘substantial,’ continues to grow
- Long-term type 2 diabetes risk continues to rise with extreme obesity
- Nasal glucagon viable option for type 1 diabetes
- Structured support aids care transition for teens with type 1 diabetes
-
- SUSTAIN-6: Retinopathy complications may be increased with semaglutide